09.01.01
Winston-Salem, NC-based Pilot Therapeutics and Quintiles, Research Triangle Park, NC, have allied to commercialize Pilot’s lead product. Under the agreement, Quintiles’ commercialization unit, Innovex, will become the exclusive sales service provider for Pilot’s natural therapy for asthma, PLT 3514. In addition, the agreement enables Quintiles to be Pilot’s preferred provider of pre-launch and future clinical development services.